دورية أكاديمية
Venetoclax or placebo in combination with bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma (BELLINI): a randomised, double-blind, multicentre, phase 3 trial
| العنوان: | Venetoclax or placebo in combination with bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma (BELLINI): a randomised, double-blind, multicentre, phase 3 trial |
|---|---|
| المؤلفون: | Kumar, Shaji K, Harrison, Simon J, Cavo, Michele, de la Rubia, Javier, Popat, Rakesh, Gasparetto, Cristina, Hungria, Vania, Salwender, Hans, Suzuki, Kenshi, Kim, Inho, Punnoose, Elizabeth A, Hong, Wan-Jen, Freise, Kevin J, Yang, Xiaoqing, Sood, Anjla, Jalaluddin, Muhammad, Ross, Jeremy A, Ward, James E, Maciag, Paulo C, Moreau, Philippe |
| المساهمون: | AbbVie, Genentech |
| المصدر: | The Lancet Oncology ; volume 21, issue 12, page 1630-1642 ; ISSN 1470-2045 |
| بيانات النشر: | Elsevier BV |
| سنة النشر: | 2020 |
| المجموعة: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| DOI: | 10.1016/s1470-2045(20)30525-8 |
| الإتاحة: | https://doi.org/10.1016/s1470-2045Test(20)30525-8 https://api.elsevier.com/content/article/PII:S1470204520305258?httpAccept=text/xmlTest https://api.elsevier.com/content/article/PII:S1470204520305258?httpAccept=text/plainTest |
| حقوق: | https://www.elsevier.com/tdm/userlicense/1.0Test/ |
| رقم الانضمام: | edsbas.1CDCC15D |
| قاعدة البيانات: | BASE |
| DOI: | 10.1016/s1470-2045(20)30525-8 |
|---|